Skip to main content
Benaroya Research Institute at Virginia Mason logo.
Menu
  • News
  • Resources
  • Careers
  • Autoimmune Life Blog
  • Contact

Search form

  • What is BRI
    • About BRI
    • Immune System Diseases
    • Scientists & Laboratories
  • Research at BRI
    • Join Our Research
    • Track Our Clinical Research
    • Type 1 Diabetes Research
    • Centers of Discovery
    • Programs
    • Recent Publications
    • Collaborations
  • For Scientists
    • Programs
    • Core Labs
    • Principal Scientist Labs
    • Scientific Staff
    • Publications
  • For Industry
    • Contact Us
    • Business Development Team
    • Available Technologies
    • Industry Collaborations
    • Clinical Research Program -- for Sponsors
  • Support BRI
    • BRI Fundraising Events
    • Become a Champion
    • Ways to Give

Donate

You are here

Home

Immune Tolerance Network

Fighting Diseases

Hope for MS Powers Support for BRI

Read about an innovative new drug trial and learn what inspired one family’s support for MS research.
Fighting Diseases

One Step Closer to Preventing Celiac Disease

Tee Bahnson published research that may have uncovered a way to prevent Celiac disease in children.
Fighting Diseases
Improving Diabetes Research Worldwide

Improving Diabetes Research Worldwide

Here are three ways we're using our expertise to improve type 1 diabetes research worldwide.
News & Views

Landmark Studies Shows Strides Against Peanut Allergies

The Immune Tolerance Network (ITN), led by Benaroya Research Institute (BRI), has made major breakthroughs in fighting peanut allergies.

News & Views

New Leadership Role

 Carla Greenbaum, MD, has been named chair of Type 1 Diabetes TrialNet.

Fighting Diseases
Research Pipeline

Pipeline Analyzes Destructive Cell

Over the last few years, several unique and pioneering technologies at BRI have been combined to create a “pipeline” approach to find and study rare disease-associated cells.

Fighting Diseases
BRI Diabetes Clinical Research Program

Working To Eliminate Type 1 Diabetes

A simple blood test for family members of those living with type 1 diabetes may detect autoantibodies that show an increased risk years before symptoms appear.

News & Views
Using Data for the Public Good

Using Data for Public Good

The Immune Tolerance Network’s TrialShare Clinical Trials Research Portal has won the National Academy of Sciences Data and Information Challenge.
Subscribe to RSS - Immune Tolerance Network

What is BRI

  • About the Institute
  • Disease Information
  • Scientists & Labs

Our Research

  • Diabetes Research
  • Biorepositories
  • Programs
  • Publications
  • Clinical Research

Newsroom

  • Autoimmune Life Blog
  • Announcements
  • In the News
  • Press Releases

Resources

  • Contact Info
  • Sign Up
  • Careers
  • Educational Opportunities
  • Community Involvement

Support

  • BRI Events
  • Become a Champion
  • Ways to Give
  • Fundraise for BRI
  • Donate Now
Benaroya Research Institute at Virginia Mason

Terms of Use Privacy Policy

© 2022 Benaroya Research Institute at Virginia Mason. 1201 Ninth Avenue, Seattle, WA 98101-2795

(206) 342-6500

  • Twitter
  • Facebook
  • LinkedIn
  • YouTube
  • Instagram